Skip to main content

Closing Bell: Biosyent Inc down on Tuesday (RX)

Automated Summaries - The Globe and Mail - Tue Jul 23, 4:02PM CDT

Biosyent Inc opened trading today at $10.16 and closed at $10.00. prices ranged from a low of $10.00 to a high of $10.16.

Shares eased -1.38 percent from the previous day's close of $10.14.

During the day across North America, the TSX Composite closed -0.26% at 22813.75, the S&P 500 closed 1.08% at 5564.41, the Dow Jones Industrial Average closed 0.32% at 40415.44 and the Nasdaq Composite closed 1.58% at 18007.57.

Biosyent Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker RX.

A total of 6,010 shares was traded during the last trading day, with total trades of 17, with an average volume of 3,247 over the last 5 days.

The TSX-V overall saw 3,093 price advancers against 2,137 declines and 96 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $10.75 (June 21,2024) and low as $7.45 (July 26,2023). Moreover, the shares have soared 33.51 percent in 52 weeks, while this year, they have advanced 8.46%.

It announced a 0.04 dividend on May 16/24, with an May 31/24 ex-date and June 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $117.46 million on a float of 11,584 shares outstanding. Its annual EPS is $0.58.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Biosyent Inc's average recommendation is "Moderate Buy" based on 1.00 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..